MENU
+Compare
ELDN
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$2.69
Change
-$0.06 (-2.18%)
Capitalization
161.08M

ELDN Eledon Pharmaceuticals Forecast, Technical & Fundamental Analysis

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more

ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ELDN with price predictions
Jun 27, 2025

ELDN's RSI Oscillator recovers from oversold territory

The RSI Indicator for ELDN moved out of oversold territory on June 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

ELDN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ELDN as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ELDN turned negative on June 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

ELDN moved below its 50-day moving average on June 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ELDN crossed bearishly below the 50-day moving average on June 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ELDN entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.406) is normal, around the industry mean (16.326). P/E Ratio (4.808) is within average values for comparable stocks, (58.407). ELDN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.310). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.768).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ELDN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ELDN is expected to report earnings to rise 171.88% to -21 cents per share on August 07

Eledon Pharmaceuticals ELDN Stock Earnings Reports
Q2'25
Est.
$-0.22
Q1'25
Beat
by $0.17
Q4'24
Missed
by $0.32
Q3'24
Est.
$-0.32
Q2'24
Missed
by $0.09
The last earnings report on May 14 showed earnings per share of -7 cents, beating the estimate of -25 cents. With 7.56M shares outstanding, the current market capitalization sits at 161.08M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
19900 MacArthur Boulevard
Phone
+1 949 238-8090
Employees
20
Web
https://www.eledon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BDAUX30.640.29
+0.96%
Baron Durable Advantage R6
HRLVX22.470.08
+0.36%
Harbor Large Cap Value Admin
FSIDX17.420.03
+0.17%
Fidelity Advisor Strategic Div & Inc I
GSMVX16.440.02
+0.12%
Goldman Sachs Small/Mid Cap Equity Instl
RYVCX144.90-0.71
-0.49%
Rydex Energy Services C

ELDN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with CDXS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
-1.82%
CDXS - ELDN
38%
Loosely correlated
-5.56%
MREO - ELDN
38%
Loosely correlated
-5.00%
ABSI - ELDN
37%
Loosely correlated
-3.51%
AMLX - ELDN
36%
Loosely correlated
-2.62%
CRNX - ELDN
35%
Loosely correlated
-1.22%
More

Groups containing ELDN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
-1.82%
pharmaceuticals
theme (152 stocks)
35%
Loosely correlated
-1.37%